Individuals With HIV Who Are Heavily Treatment Experienced


Monica Gandhi, MD, MPH
University of California San Francisco
Michael S. Saag, MD
University of Alabama at Birmingham
Paul E. Sax, MD
Harvard Medical School


Carrie D. Johnston, MD
Weill Cornell Medicine


February 16, 2021 - 10:00 AM


February 16, 2021 - 11:15 AM

Add to iCal Calendar


Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education effort for physicians on the evolving challenges of managing HIV disease. Although more uncommon with contemporary regimens, clinicians may be presented with patients in whom various regimens and drug classes have failed and who are not virally suppressed. This case-based panel discussion will review cases of individuals with HIV who are heavily treatment experienced and provide recommendations from experts in HIV research and patient care.

Learning Objectives

On completion of this webinar, learners will be able to:

  • Describe the approaches for managing individuals with HIV who are heavily treatment experienced
  • List the options for people who have multidrug-resistant virus and limited treatment options


Who Should Attend

This webinar is designed for clinical decision makers who are actively involved in HIV care and research.

This activity is also relevant for registered nurses, pharmacists, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive continuing education credit or a certificate of participation.

Registration closes on Monday, February 15, 2021, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at

Conflicts of Interest

In the interest of maintaining the independence of its continuing education activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they or their spouses or partners have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA continuing education activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Panelists and Moderator Disclosures

Dr Gandhi has no relevant financial affiliations to disclose. (Updated 12/15/20)

Dr Johnston has received grant support awarded to her institution from Gilead Sciences, Inc. (Updated 12/15/20)

Dr Sax has served as a consultant or advisor to GlaxoSmithKline/ViiV, Janssen Therapeutics, Merck & Co, Inc, and Gilead Sciences, Inc. He has received grant support awarded to his institution from Gilead Sciences, Inc, and GlaxoSmithKline/ViiV. (Updated 12/15/20)

Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc, and ViiV Healthcare. (Updated 12/15/20)

All relevant financial relationships have been mitigated.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Credits

These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo These activities are eligible for ACPE credit, see final CPE activity announcement for specific details.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.


Gilead Sciences, Inc
Merck & Co, Inc
ViiV Healthcare


Janssen Therapeutics

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at or 415-544-9400.